Remember this article? I think we ride this one out.
This is one paragraph of an article from a few weeks back.
Since receiving approval for the gram-positive test, Nanosphere says interest from hospitals in the Verigene System has been through the roof. We can't quantify demand until we get through the summer and into the fourth quarter because of the lag between approval, installation of the platform at hospitals and revenue generated from the new test. By all indications, however, interest from hospitals is very high.
I think most investors these days won't invest on potential alone anymore. They want to see good numbers first. They are going to get their good numbers very soon, but it will be you and I and others like us who make the big bucks. With today's ultra fast electronic trading systems coupled with every tom dick and harry trading from home full time, the prices move far too swiftly to wait until the last minute to get in and make any substantial money.
I've been in the market decades and I've never been more sure of an investment in my life. I've been lucky enough to retire in my mid-40's, however I still enjoy picking good stocks to invest in. NSPH is my all-time favorite for several reasons, not least of which its revolutionary life saving ability.
I would like to see stats from the company that go beyond information such as "off the charts interest". Like: how many systems they are capable of producing a month and what monthly sales / placement numbers are running for their systems. Numbers of units placed in hospitals = greater cartridge use. And, are they ramping up their sales/service personnel force to meet implied demand.